Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diabetic Retinopathy as a Marker of Cognitive Dysfunction and Depression

NCT04610749 is registered in ClinicalTrials.gov with Region of Southern Denmark as lead sponsor.

NCT NCT04610749
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04610749 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diabetic Retinopathy as a Marker of Cognitive Dysfunction and Depression
Lead sponsor
Region of Southern Denmark
Phase
Observational
Overall status
Completed
Start date
November 25, 2020
Completion date
February 25, 2022
Enrollment
148 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive dysfunction, cognitive impairment, depression, diabetic retinopathy